Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Biometrical Journal. Biometrische Zeitschrift|March 26, 2019
Dynamic prediction: A challenge for biostatisticians, but greatly needed by patients, physicians and the publicMartin Schumacher, Stefanie Hieke, Gabriele Ihorst, et al.Cytotherapy|September 3, 2013
Lowering the alemtuzumab dose in reduced intensity conditioning allogeneic hematopoietic cell transplantation is associated with a favorable early intense natural killer cell recoveryFrank Gärtner, Stefanie Hieke, Jürgen Finke, et al.Biometrical Journal. Biometrische Zeitschrift|May 22, 2012
Nonparametric inference for the cumulative incidence function of a competing risk, with an emphasis on confidence bands in the presence of left-truncationSusanna Di Termini, Stefanie Hieke, Martin Schumacher, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2015
Conditional Survival: A Useful Concept to Provide Information on How Prognosis Evolves over TimeStefanie Hieke, Martina Kleber, Christine König, et al.Plos One|May 10, 2016
Identifying Prognostic SNPs in Clinical Cohorts: Complementing Univariate Analyses by Resampling and Multivariable ModelingStefanie Hieke, Axel Benner, Richard F Schlenk, et al.Pharmacoepidemiology and Drug Safety|May 30, 2012
Use of systemic antifungals in daily clinical practice in the haematology and oncology setting: results of a prospective observational analysisBarbara Metzke, Werner Christian Neubauer, Stefanie Hieke, et al.Annals of Hematology|July 4, 2012
Treatment option of bendamustine in combination with rituximab in elderly and frail patients with aggressive B-non-Hodgkin lymphoma: rational, efficacy, and toleranceJulia Horn, Martina Kleber, Stefanie Hieke, et al.BMC Bioinformatics|September 1, 2016
Integrating multiple molecular sources into a clinical risk prediction signature by extracting complementary informationStefanie Hieke, Axel Benner, Richard F Schlenl, et al.Journal of Central Nervous System Disease|October 25, 2024
Best supportive care for patients with primary progressive multiple sclerosis (PPMS) in Germany prior to ocrelizumab treatment: Final results from the RETRO PPMS studyHerbert Schreiber, Iris-Katharina Penner, Tanja Maier, et al.Antimicrobial Agents and Chemotherapy|June 16, 2010
Therapeutic drug monitoring of posaconazole in hematology patients: experience with a new high-performance liquid chromatography-based methodWerner Christian Neubauer, Monika Engelhardt, Armin König, et al.Pageof 2